Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease
Thomas P Spargo,
No information about this author
Chloe F. Sands,
No information about this author
Isabella R. Juan
No information about this author
et al.
Cell Reports,
Journal Year:
2025,
Volume and Issue:
unknown, P. 115355 - 115355
Published: March 1, 2025
Highlights•ITSN1
haploinsufficiency
confers
a
∼10-fold
increased
risk
of
Parkinson's
disease
(PD)•Effect
size
surpasses
other
well-established
loci,
including
GBA1
and
LRRK2•In
vivo
in
vitro
studies
suggest
an
interaction
between
ITSN1
α-synuclein•Findings
implicate
synaptic
vesicle
trafficking
dysfunction
PD
pathogenesisSummaryDespite
its
significant
heritability,
the
genetic
basis
(PD)
remains
incompletely
understood.
Here,
analyzing
whole-genome
sequence
data
from
3,809
cases
247,101
controls
UK
Biobank,
we
discover
that
protein-truncating
variants
confer
substantially
(p
=
6.1
×
10−7;
odds
ratio
[95%
confidence
interval]
10.5
[5.2,
21.3]).
We
replicate
this
association
three
independent
datasets
totaling
8,407
413,432
(combined
p
4.5
10−12).
Notably,
has
also
been
associated
with
autism
spectrum
disorder,
suggesting
variable
penetrance/expressivity.
In
Drosophila,
find
loss
ortholog
Dap160
exacerbates
α-synuclein-induced
neuronal
toxicity
motor
deficits,
assays
further
physical
α-synuclein.
These
results
firmly
establish
as
gene
effect
exceeding
previously
established
vesicular
pathogenesis,
potentially
open
new
avenues
for
therapeutic
development.Graphical
abstract
Language: Английский
Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson’s disease risk
Nature Aging,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 21, 2024
Parkinson's
disease
(PD)
is
an
incurable,
progressive
and
common
movement
disorder
that
increasing
in
incidence
globally
because
of
population
aging.
We
hypothesized
the
landscape
rare,
protein-altering
variants
could
provide
further
insights
into
pathogenesis.
Here
we
performed
whole-exome
sequencing
followed
by
gene-based
tests
on
4,298
PD
cases
5,512
controls
Asian
ancestry.
showed
GBA1
SMPD1
were
significantly
associated
with
risk,
replication
a
5,585
5,642
controls.
refined
variant
classification
using
vitro
assays
reduced
enzymatic
activity
display
strongest
association
(<44%
activity,
odds
ratio
(OR)
=
2.24,
P
1.25
×
10−15)
risk.
Moreover,
80.5%
carriers
harbored
Asian-specific
p.Pro332Arg
(OR
2.16;
4.47
10−8).
Our
findings
highlight
utility
performing
exome
diverse
ancestry
groups
to
identify
rare
genes
previously
unassociated
disease.
Using
assays,
Chew,
Liu,
Li,
Chung
et
al.
identified
protein-coding
associate
risk
across
cohorts
descent.
Language: Английский